Lunesta Sales Data
| Rank 72 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Lunesta U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 72 ( 5) |
$225,101 | 5.24% | 284 | -6.58% |
| Q3 2013 | 77 (5) |
$213,900 | 7.57% | 304 | -6.17% |
| Q2 2013 | 82 (8) |
$198,841 | 5.05% | 324 | -3.57% |
| Q1 2013 | 90 ( 3) |
$189,289 | -1.43% | 336 | -2.61% |
| Q4 2012 | 87 (6) |
$192,034 | 4.83% | 345 | 0.88% |
| Q3 2012 | 93 (4) |
$183,190 | 2.23% | 342 | 2.40% |
| Q2 2012 | 89 (2) |
$179,192 | -4.66% | 334 | -4.02% |
| Q1 2012 | 87 (5) |
$187,941 | -4.30% | 348 | -5.18% |
| Q4 2011 | 82 (1) |
$196,388 | 4.17% | 367 | -0.27% |
| Q3 2011 | 81 (5) |
$188,531 | -3.44% | 368 | -2.39% |
| Q2 2011 | 76 (3) |
$195,242 | -2.53% | 377 | -2.58% |
| Q1 2011 | 79 | $200,317 | n/a | 387 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
Related news
| Date | Article |
|---|---|
| August 24, 2022 | America's Love Affair With Sleeping Pills May Be Waning |
